'SNO'-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders

被引:45
|
作者
Nakamura, Tomohiro [1 ,2 ,3 ,4 ]
Lipton, Stuart A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Scripps Res Inst, Neurosci Translat Ctr, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA
[4] Scintillon Inst, Neurodegenerat Dis Ctr, San Diego, CA 92121 USA
[5] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA
来源
关键词
NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; BRAIN ENERGY-METABOLISM; CYTOCHROME-C-OXIDASE; NITRIC-OXIDE; S-NITROSYLATION; COMPLEX-I; CELL-DEATH; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PERSISTENT INHIBITION; PARKINSONS-DISEASE;
D O I
10.1016/j.tem.2017.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), is currently a major public health concern due to the lack of efficient disease-modifying therapeutic options. Recent evidence suggests that mitochondrial dysfunction and nitrosative/oxidative stress are key common mediators of pathogenesis. In this review, we highlight molecular mechanisms linking NO-dependent post-translational modifications, such as cysteine S-nitrosylation and tyrosine nitration, to abnormal mitochondrial metabolism. We further discuss the hypothesis that pathological levels of NO compromise brain energy metabolism via aberrant S-nitrosylation of key enzymes in the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, contributing to neurodegenerative conditions. A better understanding of these pathophysiological events may provide a potential pathway for designing novel therapeutics to ameliorate neurodegenerative disorders.
引用
收藏
页码:879 / 892
页数:14
相关论文
共 50 条
  • [1] Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders
    Ikawa, Masamichi
    Okazawa, Hidehiko
    Yoneda, Makoto
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2021, 1865 (03):
  • [2] Mitochondrial dysfunction in neurodegenerative disorders
    Baron, M.
    Kudin, A. P.
    Kunz, W. S.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1228 - 1231
  • [3] Mitochondrial dysfunction in neurodegenerative disorders
    Schapira, AHV
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1366 (1-2): : 225 - 233
  • [4] MITOCHONDRIAL DISORDERS IN NEURODEGENERATIVE DISEASES
    Aydin, Makbule
    IUBMB LIFE, 2009, 61 (03) : 315 - 316
  • [5] Mitochondrial dysfunction in neurodegenerative disorders
    Hattori, Nobutaka
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 62 (01) : S12 - S12
  • [6] Mitochondrial genes and neurodegenerative disorders
    Parker, WD
    Swerdlow, R
    JOURNAL OF CLINICAL LIGAND ASSAY, 2000, 23 (02): : 141 - 143
  • [7] Mitochondrial dysfunction in neurodegenerative disorders
    Klemmensen, Madelyn M.
    Borrowman, Seth H.
    Pearce, Colin
    Pyles, Benjamin
    Chandra, Bharatendu
    NEUROTHERAPEUTICS, 2024, 21 (01)
  • [8] Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism-related Molecule in Neurodegeneration
    Khodagholi, Fariba
    Shaerzadeh, Fatemeh
    Montazeri, Fateme
    CURRENT DRUG TARGETS, 2018, 19 (08) : 973 - 985
  • [9] Role of metabolism in neurodegenerative disorders
    Procaccini, Claudio
    Santopaolo, Marianna
    Faicchia, Deriggio
    Colamatteo, Alessandra
    Formisano, Luigi
    de Candia, Paola
    Galgani, Mario
    De Rosa, Veronica
    Matarese, Giuseppe
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (09): : 1376 - 1390
  • [10] Misconnecting the dots: altered mitochondrial protein-protein interactions and their role in neurodegenerative disorders
    Zilocchi, Mara
    Moutaoufik, Mohamed Taha
    Jessulat, Matthew
    Phanse, Sadhna
    Aly, Khaled A.
    Babu, Mohan
    EXPERT REVIEW OF PROTEOMICS, 2020, 17 (02) : 119 - 136